Open AccessHigh-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
Author(s) -
Tom Decroo,
Bouke C. de Jong,
Alberto Piubello,
Mahamadou Bassirou Souleymane,
Lutgarde Lynen,
Armand Van Deun
Publication year - 2020
Publication title -
american journal of respiratory and critical care medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.272
H-Index - 374
eISSN - 1535-4970
pISSN - 1073-449X
DOI - 10.1164/rccm.202001-0201le
Subject(s) - medicine , rifampicin , tuberculosis , regimen , pyrazinamide , tb treatment , pathology